Mon panier

Cynomolgus Integrin alpha 5 beta 1 (ITGA5&ITGB1) Heterodimer Protein, His Tag&Tag Free (MALS verified)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
IT1-C52W7-100ug
$485.00
IT1-C52W7-1mg (500ug X 2)
$3265.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Synonyms

    Integrin alpha 5 beta 1, ITGA5&ITGB1

  • Source

    Cynomolgus ITGA5&ITGB1 Heterodimer Protein, His Tag&Tag Free (IT1-C52W7) is expressed from human 293 cells (HEK293). It contains AA Phe 42 - Tyr 999 (ITGA5) & Gln 161 - Asp 868 (ITGB1) (Accession # XP_005571144.3 (ITGA5) & A0A7N9D0D7 (ITGB1)).

    Predicted N-terminus: Phe 42 (ITGA5) & Gln 161 (ITGB1)

    Request for sequence
  • Molecular Characterization

    Integrin alpha 5 beta 1 Structure

    Other Tags and Version Biotin & Other Labeled Version

    Cynomolgus ITGA5&ITGB1 Heterodimer Protein, His Tag&Tag Free, produced by co-expression of ITGA5 and ITGB1, has a calculated MW of 111.2 kDa (ITGA5) & 83.6 kDa (ITGB1). Subunit ITGA5 is fused with an acidic tail at the C-terminus and followed by a polyhistidine tag and subunit ITGB1 contains no tag but a basic tail at the C-terminus. The protein migrates as 130-160 kDa (ITGA5) and 95-110 kDa (ITGB1) when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (NR) condition (SDS-PAGE) due to glycosylation.

    The protein is designed as a heterodimer.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >95% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 50 mM HEPES, 150 mM NaCl, pH7.5 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • SDS-PAGE

    Integrin alpha 5 beta 1 SDS-PAGE

    Cynomolgus ITGA5&ITGB1 Heterodimer Protein, His Tag&Tag Free on SDS-PAGE under non-reducing (NR) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    Integrin alpha 5 beta 1 SEC-MALS

    The purity of Cynomolgus ITGA5&ITGB1 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT1-C52W7) is more than 90% and the molecular weight of this protein is around 200-240 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     Integrin alpha 5 beta 1 ELISA

    Immobilized Recombinant Fibronectin fragment, premium grade (Cat. No. FIN-H5116) at 2 μg/mL (100 μL/well) can bind Cynomolgus ITGA5&ITGB1 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT1-C52W7) with a linear range of 10-78 ng/mL (QC tested).

    Protocol

Avis des utilisateurs
Publier un commentaire

Introduction de fond

Integrin alpha 5 beta 1 / Integrin α5β1, which is a major cellular receptor for the extracellular matrix protein fibronectin and plays a fundamental role during mammalian development., is composed of α5 (ITGA5/CD49e) and β1 (ITGB1/CD29) subunits. Integrins are adhesion receptors that transmit bidirectional signals across the plasma membrane. The Integrin alpha 5 beta 1 and its primary extracellular matrix ligand fibronectin (Fn) are of great biological importance.

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Integrin alpha-5/beta-1

  • Catégorie:

  • Nombre de médicaments répertoriés:

    1 Détails

  • Nombre de médicaments cliniques:

    4 Détails

  • Étape de développement la plus élevée:

    Approved

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • Contexte